The Sculptique Aesthetics
Semaglutide (Ozempic/Wegovy) Dosage Guide: Complete Weight Loss Protocol for India & Mumbai (2026)
Semaglutide dosage for weight loss — complete escalation schedule, starting dose, maintenance dose, what to do when you miss an injection, side effects and medically supervised protocols from The Sculptique Aesthetics Mumbai and India.
Semaglutide dosage for weight loss follows a specific escalation schedule — and the most common reason patients give up on it is getting the escalation wrong. Escalate too fast and side effects (nausea, vomiting, fatigue) overwhelm the experience. Stay on too low a dose for too long and results plateau. Find the sweet spot and semaglutide — the active ingredient in Ozempic and Wegovy — becomes one of the most effective tools for sustained weight loss in modern medicine.
If you're searching for semaglutide dosage for weight loss, Ozempic dosage in India, how much semaglutide to inject, semaglutide starting dose, semaglutide 2.4 mg dose, Ozempic 0.5 mg vs 1 mg vs 2 mg, how to escalate semaglutide, or semaglutide side effects by dose, this guide covers the complete clinical protocol used in India and internationally.
The Sculptique Aesthetics offers medically supervised weight loss including GLP-1 agonist protocols in Mumbai, Bandra, Khar, Andheri, South Mumbai and across India. Semaglutide is a prescription medication in India — it requires a proper consultation and medical prescription, not an online order.
What is semaglutide and how does it cause weight loss?
Semaglutide is a GLP-1 receptor agonist — a synthetic analogue of glucagon-like peptide-1 (GLP-1), a hormone naturally released by the gut after eating. GLP-1 signals to the brain (hypothalamus) to reduce appetite, signals the pancreas to increase insulin and reduce glucagon, and slows gastric emptying (food stays in the stomach longer, so you feel full for longer).
How semaglutide differs from natural GLP-1: natural GLP-1 has a half-life of minutes. Semaglutide has a half-life of approximately 7 days — one weekly subcutaneous injection maintains receptor activation throughout the week.
Weight loss mechanism:
- Appetite suppression: reduced hunger and earlier satiety signals from the hypothalamus
- Reduced food cravings: dopaminergic effects on the brain's reward centre reduce the drive to eat palatable, high-calorie food
- Slower gastric emptying: food stays in the stomach longer; fullness lasts longer
- Improved insulin sensitivity: better blood glucose regulation reduces hunger spikes
- Blood sugar stabilisation: reduces glucose excursions that drive cravings
See Ozempic for weight loss in Mumbai and Ozempic vs Mounjaro for broader context.
Semaglutide dosage — the escalation schedule
The semaglutide dose escalation schedule is the most important thing to understand. The drug must be started at a low dose and increased slowly — skipping steps causes intolerable side effects that cause discontinuation.
Semaglutide dose escalation for weight loss (Wegovy protocol)
| Week | Dose | Notes |
|---|---|---|
| Weeks 1–4 | 0.25 mg SC once weekly | Starting / introductory dose. Not a therapeutic weight-loss dose — purely for GI tolerance. |
| Weeks 5–8 | 0.5 mg SC once weekly | First therapeutic dose for many patients. |
| Weeks 9–12 | 1.0 mg SC once weekly | Significant appetite suppression for most. |
| Weeks 13–16 | 1.7 mg SC once weekly | Bridge dose (Wegovy escalation path). |
| Week 17+ | 2.4 mg SC once weekly | Maximum approved dose for weight loss (Wegovy). |
Ozempic dose escalation (approved for Type 2 diabetes but widely used off-label for weight loss in India):
| Week | Dose | Notes |
|---|---|---|
| Weeks 1–4 | 0.25 mg SC once weekly | Starting dose |
| Weeks 5+ | 0.5 mg SC once weekly | Maintenance for diabetes; many weight-loss patients progress further |
| As needed | 1.0 mg SC once weekly | Most common weight-loss dose with Ozempic pen |
| Maximum | 2.0 mg SC once weekly | Ozempic's maximum approved dose (higher than Wegovy in some markets) |
Important: if a patient cannot tolerate a dose escalation, stay at the previous dose for an additional 4 weeks before retrying. Do not escalate through intolerable nausea — it is both unnecessary and counterproductive.
Semaglutide maintenance dose
There is no single "correct" maintenance dose — it is the lowest dose that:
- Maintains meaningful appetite suppression
- Is well tolerated without persistent side effects
- Supports continued progress toward your weight goal
Many patients reach their maintenance at 1.0 mg or 1.7 mg weekly. Some need 2.4 mg to achieve meaningful suppression. Clinically, we see the best long-term compliance at the dose that is effective and comfortable — usually not the highest possible dose.
Semaglutide dosage for different starting points
BMI 27–30 (overweight, comorbidity-driven)
- Start: 0.25 mg × 4 weeks
- Escalate: standard schedule
- Target: 1.0–1.7 mg maintenance in many cases
- Duration: 6–12 months minimum; reassess at goal weight
BMI 30–35 (mild obesity)
- Start: 0.25 mg × 4 weeks
- Escalate: standard schedule
- Target: 1.7–2.4 mg for full benefit
- Expected weight loss at 2.4 mg over 68 weeks: approximately 12–15 % of body weight (STEP trial data)
BMI 35+ (moderate to severe obesity)
- Start: 0.25 mg × 4 weeks
- Escalate: standard schedule, not accelerated
- Target: 2.4 mg if tolerated
- Expected weight loss: up to 15–17 % of body weight in clinical trials
- Consider combining with: dietary intervention, behavioural support, activity programme
Type 2 diabetes co-management
- Start: 0.25 mg × 4 weeks → 0.5 mg maintenance (diabetes dosing)
- For additional weight benefit: progress to 1.0 mg or 2.0 mg Ozempic
- Blood glucose monitoring: required; medication doses for diabetes may need adjustment as blood sugar improves
What is the best day to inject semaglutide?
Day of the week is not clinically important — choose any day and keep it consistent. The 7-day half-life means the injection maintains stable levels throughout the week regardless of timing.
Meal timing: no requirement. Semaglutide can be injected with or without food, with or without water.
Best injection sites: abdomen (preferred — most consistent absorption), outer thigh, upper arm. Rotate sites to prevent lipoatrophy.
How to inject: subcutaneous, using the pre-filled auto-injector pen (Ozempic or Wegovy). Pinch skin gently, insert needle fully, press button, hold for 6 seconds to ensure full dose delivery.
What happens if I miss a semaglutide injection?
- Missed by less than 5 days: inject as soon as you remember
- Missed by more than 5 days: skip the missed dose; continue on your normal day next week
- Never double-dose — never inject two doses in one week to compensate
How much weight loss can I expect from semaglutide?
Based on STEP clinical trial data (2.4 mg weekly, 68 weeks):
- Average weight loss: 12.4 % of body weight (approximately 15 kg for an 80 kg patient)
- Patients achieving ≥5 % loss: ~87 %
- Patients achieving ≥10 % loss: ~66 %
- Patients achieving ≥15 % loss: ~48 %
Individual variation is significant. Results depend on baseline weight, dietary adherence, activity level, metabolic health and dose reached. Semaglutide is most effective as part of a comprehensive plan — not as a standalone "inject and eat normally" approach.
See Ozempic for weight loss in Mumbai and Ozempic dosage for weight loss in India.
Semaglutide vs Tirzepatide (Mounjaro): which has the better dose/effect ratio?
This is the most frequently asked comparison at our clinic. Tirzepatide (Mounjaro) is a dual GIP/GLP-1 agonist — it activates two pathways compared to semaglutide's one. In the SURMOUNT-1 trial, tirzepatide at 15 mg achieved 20.9 % average weight loss vs semaglutide's ~12–15 %.
For patients who respond incompletely to semaglutide, stepping up to tirzepatide often adds meaningful additional weight loss. See Ozempic vs Mounjaro and the full tirzepatide dosage guide.
Semaglutide side effects by dose
Most common (GI — dose-dependent)
- Nausea — most common at dose escalation; typically subsides within 1–2 weeks at each new dose level. Manage by: eating smaller meals, avoiding fatty/spicy food, taking the injection in the evening before bed.
- Vomiting — if persistent (2+ days per week), pause escalation; stay at current dose until GI settles
- Diarrhoea or constipation — common early; usually self-resolving
- Reduced appetite — desired effect but can cause under-eating; maintain adequate protein (≥1.2 g/kg/day)
- Fatigue — common early, usually weeks 1–4; resolves
Less common
- GERD / reflux — slowed gastric emptying can worsen reflux; manage with smaller meals and elevated head position after eating
- Injection site reactions — mild redness, bruising; rotate sites
Rare but serious
- Pancreatitis: stop immediately and seek emergency care if you develop severe, persistent upper abdominal pain radiating to the back
- Gallbladder disease: semaglutide increases gallstone risk (rapid weight loss also increases this independently)
- Thyroid C-cell tumours: observed in rodent studies; no confirmed human risk, but semaglutide is contraindicated in personal or family history of medullary thyroid cancer or MEN2
Who should not use semaglutide
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple endocrine neoplasia type 2 (MEN2)
- Pancreatitis history (relative contraindication — assess case by case)
- Pregnancy and breastfeeding
- Severe gastrointestinal disease (gastroparesis, bowel obstruction)
- Type 1 diabetes (without specialist supervision)
Managing semaglutide side effects — practical guide
| Side effect | Management |
|---|---|
| Nausea | Eat small meals; avoid fatty/fried food; inject at bedtime; ginger tea |
| Vomiting | Stay at current dose; do not escalate; antiemetic if prescribed |
| Constipation | Increase water and fibre; walking; osmotic laxative if needed |
| Fatigue | Ensure adequate caloric intake; monitor protein; iron if depleted |
| Hair loss | Adequate protein (≥1.2 g/kg/day); zinc supplementation; usually self-resolving |
| Muscle loss | Resistance training; protein; consider CJC-1295 / Ipamorelin alongside |
Semaglutide storage
- Unopened pens: refrigerate at 2–8 °C; do not freeze; valid until expiry date
- In-use pens: can be kept at room temperature (below 30 °C) for up to 56 days (Ozempic) or 28 days (Wegovy); keep away from direct sunlight
Frequently asked questions
0.25 mg once weekly for the first 4 weeks. This is a tolerance-building dose only — not a therapeutic weight-loss dose. Escalate to 0.5 mg after 4 weeks if tolerated.
2.4 mg once weekly (Wegovy approved dose for obesity). 2.0 mg once weekly (Ozempic maximum). Dose escalation beyond what is tolerated is never recommended.
Once weekly, on the same day each week. The 7-day half-life maintains stable blood levels throughout the week.
Most patients notice reduced appetite within 2–4 weeks at the 0.5 mg dose. Visible weight loss typically becomes measurable at 4–8 weeks. Peak effect at the therapeutic dose (1.7–2.4 mg) takes 16–20 weeks to establish.
Weight typically begins to return over weeks to months after stopping — this is the nature of GLP-1 agonism, not a flaw. Most patients require long-term or indefinite use at a maintenance dose, or transition to lifestyle strategies capable of maintaining the new weight set-point. We plan exit and maintenance strategies at consultation.
Semaglutide reduces appetite — it doesn't make poor food choices irrelevant. The best results come from pairing it with a high-protein, whole-food diet and regular activity. Patients who "eat around" the appetite suppression by consuming high-calorie liquids or processed foods will see inferior results.
Ozempic is available in India as a prescription medication for diabetes management. The obesity indication (Wegovy) has more limited availability. At The Sculptique Aesthetics we navigate availability for you under proper medical supervision. See Ozempic for weight loss in Mumbai.
Book your semaglutide consultation in Mumbai
Semaglutide is a prescription medication — it should be started, escalated and monitored by a clinician who understands your full health picture. At The Sculptique Aesthetics we assess your cardiovascular health, metabolic panel, goals and lifestyle before prescribing, and we monitor throughout.
Contact us to discuss whether semaglutide, Mounjaro (tirzepatide), or retatrutide is the right protocol for your goals. Serving Mumbai, Bandra, Khar, Andheri, Powai, Juhu, South Mumbai and international patients seeking supervised medical weight loss in India.
